Carl-Johan Aurell

USPTO Granted Patents = 22 (Patent Applications = 2)

CIPO Patents = 4 (Patent Applications = 1)

EPO Patents = 5 (Patent Applications = 7)

Average Co-Inventor Count = 7.7

ph-index = 6

Forward Citations = 198(Granted Patents)

Location History:

Malmo, SE (1995)
Södert{hacek over (a)}lje, SE (2008)
Sodertalje, SE (2015)
Alderley Park, GB (2015)
Gothenburg, SE (2021)
Molndal, SE (2000 - 2023)
Mölndal, SE (2008 - 2024)

Company Filing History:

where one patent can have more than one assignee

Years Active: 1995-2024

Loading Chart...

22 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12054465 - Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitors (2024-08-06),

2. 11814359 - Certain (2s)-n-[(1s)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitors (2023-11-14),

3. 11773069 - Certain (2s)-n-[(1s)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitors (2023-10-03),

4. 11680049 - Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitors (2023-06-20),

5. 11673872 - Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitors (2023-06-13),

6. 11673871 - Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitors (2023-06-13),

7. 11667615 - Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitors (2023-06-06),

8. 11655224 - Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitors (2023-05-23),

9. 11655223 - Certain (2S)-N-[(1 s)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitors (2023-05-23),

10. 11655222 - Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitors (2023-05-23),

11. 11655221 - Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitors (2023-05-23),

12. 11149029 - Salts of IJAK inhibitors and methods of using the same (2021-10-19),

13. 11117874 - Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitors (2021-09-14),

14. 10669245 - Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides dipeptidyl peptidase 1 inhibitors (2020-06-02),

15. 10287258 - Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitors (2019-05-14),

Title: The Innovative Mind of Carl-Johan Aurell

Introduction: Carl-Johan Aurell, a distinguished inventor hailing from Mölndal, SE, is renowned for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Carl-Johan Aurell's latest patents showcase his expertise in developing cutting-edge solutions for various industries, including robotics, artificial intelligence, and renewable energy.

Career Highlights: With a career spanning over two decades, Carl-Johan Aurell has established himself as a visionary inventor with a keen eye for identifying gaps in the market and creating innovative solutions to address them. His work has not only revolutionized existing technologies but has also paved the way for new advancements in the industry.

Collaborations: Throughout his career, Carl-Johan Aurell has collaborated with leading tech companies, research institutions, and universities to bring his inventions to life. His ability to work seamlessly with multidisciplinary teams has been instrumental in the success of many projects.

Conclusion: In conclusion, Carl-Johan Aurell's passion for innovation, coupled with his technical expertise, has solidified his position as a trailblazer in the world of technology. His relentless pursuit of excellence and commitment to pushing the boundaries of what is possible continue to inspire inventors and innovators worldwide.

This text is generated by artificial intelligence and may not be accurate.